Skip to main content

Investor Corner:  Frequently Asked Questions & Answers

Save time and find answers to frequently asked questions about us and our business. Note that we offer investments under Rule 506(c) only to accredited investors.

Company
Business
Risk Factors
Offerings
More Information
Company

Q: What is Metallomix? 

A: Metallomix Inc. is a clinical stage biotech company targeting isotopic dysfunction – a previously unrecognized driver of cancer and diseases of aging including neurodegenerative diseases. The metallome – metals in human biology and disease – plays an integral role in various biological functions, including amino acid and protein synthesis, DNA integrity and repair, and mitochondrial metabolism.  We are leading the way in illuminating a metallome much more nuanced than simply the function of specific metals or oxidation states, offering a massive and previously unexplored opportunity for drug discovery and development. 

Business
Risk Factors
Offerings
More Information

Q: Where can potential investors find more information? 

A: We have agreed to make available to each prospective investor the opportunity to ask questions and to receive answers from our officers concerning the terms and conditions of investing into our business, and to obtain any additional information, to the extent we possess such information or can acquire it without unreasonable effort or expense. You may mail or email your questions, inquiries, and requests to: 

Metallomix, Inc.
Attn: Investor Relations

175 SW 7-th Street, Unit 1702, Miami, Florida 33130

                                 eMail: IR@Metallomix.com